【放療】GE旗下「MR Contour DLiii」使用DL進行「描繪危及器官」分割，獲FDA批准

 【放療】GE旗下「MR Contour DLiii」使用DL進行「描繪危及器官(OAR)」分割，獲FDA 510(k)批准

 文章出處  

Businesswire 

 

 原文標題  

ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions 

 

 Twitter  

https://x.com/aimedadviser/status/1919167753270730883 

 

 文章序號  

7886 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.